Category: Health Services

ABU DHABI, The Ministry of Health and Prevention (MoHAP) has announced that 69,453 doses of the COVID-19 vaccine were given in the past 24 hours.

The total number of doses provided up to today stands at 15,865,306 with a rate of vaccine distribution of 160.41 doses per 100 people.

This is in line with the Ministry’s plan to provide the COVID-19 vaccine to all members of society and efforts to reach acquired immunity resulting from the vaccination, which will help reduce the number of cases and control the virus.

Source: Emirates News Agency

ABU DHABI, The Ministry of Health and Prevention (MoHAP) announced that it conducted 287,544 additional COVID-19 tests over the past 24 hours, using state-of-the-art medical testing equipment.

In a statement, the Ministry stressed its aim to continue expanding the scope of testing nationwide to facilitate the early detection of coronavirus cases and carry out the necessary treatment. As part of its intensified testing campaign, MoHAP announced 1,513 new coronavirus cases, bringing the total number of recorded cases in the UAE to 644,114.

According to the Ministry, the infected individuals are from various nationalities, are in a stable condition, and receiving the necessary care.

MoHAP also announced 4 deaths due to COVID-19 complications, bringing the total number of deaths in the country to 1,847.

The Ministry expressed its sincere condolences to the family of the deceased and wished COVID-19 patients a speedy and full recovery. It called on all members of the society to cooperate with health authorities, adhere to the instructions and physical distance to ensure the health and safety of all.

MoHAP also noted that an additional 1,489 individuals had fully recovered from COVID-19, bringing the total number of recoveries to 622,301.

Source: Emirates News Agency

ABU DHABI, Abu Dhabi National Insurance Company (ADNIC), a leading regional multi-line insurance provider for both corporate and individual customers, has partnered with Ajman Free Zone (AFZ) to provide health insurance plans for registered investors and entities.

The agreement was signed by Alya Al Tamimi, Vice President – Branches and Direct Sales of ADNIC and Ali AlSuwaidi, Director-General of Ajman Free Zone.

Under the agreement, AFZ registrants will benefit from a variety of exclusive pre-underwritten plans tailor made to their needs without the need to submit an individual application form, delivering a seamless customer journey experience.

The free zone is home to more than 9,000 companies, investors, and entrepreneurs from over 160 countries.

Ahmad Idris, CEO of ADNIC, said, “We are delighted to support Ajman Free Zone in its efforts to provide exceptional benefits to entities and individuals. The agreement will provide access to tailored health insurance schemes that will be an added benefit contributing to the free zone’s ever-growing success. This partnership entrusts ADNIC to serve as a key touch point to all insurance related services, and we look forward to acknowledge that trust by providing an exceptional experience to all.”

Ali AlSuwaidi remarked, “At Ajman Free Zone, we hold the healthcare sector in high regard, given its contribution not only to our economy, but also to our society. We are pleased with this strategic partnership with ADNIC, especially since healthcare is one of the most vital sectors that continue to be a priority in our present and future goals. This achievement, in line with customer welfare as a focus value of AFZ, will empower us to offer more value-added services to our esteemed partners. AFZ is always committed to collaborating with the best industry players and expanding our already-existing partnerships to offer more efficient services and an attractive environment for the health and happiness of investors, companies, customers, and employees.”

Source: Emirates News Agency

DUBAI, The 20th edition of the Dubai World Dermatology and Laser Conference and Exhibition ( Dubai Derma) is set to take place from 6th to 8th July 2021 at the Dubai World Trade Centre.

This year, Dubai Derma will feature various scientific lectures, courses and workshops presented by some of the most prominent experts in the field. More than 14,500 scientists, doctors and specialists from 110 countries will take part in the event.

The 20th edition of Dubai Derma, held under the theme ‘Skin Health is our Concern’, will feature the participation of world-renowned dermatologists, aesthetic specialists, surgeons, laser specialists, hair specialists, allied healthcare professionals including nurse assistants, technicians, auxiliary, medical spa therapists, and leading skincare companies.

Awadh Al Ketbi, Director-General of the Dubai Health Authority, said that this global event and other important international events and activities highlight the Emirate’s capability to host events keeping all precautionary measures in mind.

He also highlighted that the medical field is ever evolving and such events present an opportunity to exchange knowledge and expertise with an aim to further advance medical care.

The exhibition will feature over 500 brands by 250 international companies, who will showcase their latest innovations and technologies in the field of Dermatology and Laser.

Source: Emirates News Agency

ABU DHABI, Abu Dhabi Public Health Centre (ADPHC) in collaboration with the Abu Dhabi Department of Health (DOH) have launched the first investigation and contact tracing system in the region – the “Contact Tracing Assistant System”. The system is designed to conduct a virtual chat with positive COVID-19 cases.

The goal of this system is to expand the scope of COVID-19 investigations to be more comprehensive, help predict and prevent COVID-19 transmission between community members, and communicate efficiently with positive cases in the shortest possible time.

Once a positive case receives his/her COVID-19 result, the system automatically sends them an SMS with a link for the virtual chat. After verification of his\her Emirates ID is completed, the person will proceed with dialogue by answering specific questions to complete the process.

The system allows the investigation and contact tracing team to gather necessary information, such as who is returning from abroad, or a workplace, or who has recently come in contact with a positive case, to expand the investigation process.

It will also ask for a list of possible contacts 48 hours before the positive result. The information obtained will be considered confidential and will not be shared with anyone outside the investigation team. In addition, the centre’s team will review the data entered and make any necessary calls to complete missing or unclear information.

The system is available only in Arabic and English.

On this occasion, Abdulla bin Mohamed Al Hamed, Chairman of DOH, thanked the country’s leadership for their continuous support, which enabled Abu Dhabi to make remarkable achievements in responding to the coronavirus pandemic, to lead by example globally, and to ensure the health and safety of the emirate’s community.

Al Hamed said, “Abu Dhabi has led by example and used advanced technology in tracing virus transmission. The new Contact Tracing Assistant System will help in controlling the transmission and ensure the health and safety of all members of the community. We praise all the efforts shown by the centre since the beginning of the pandemic.”

Matar Al Nuaimi, Director-General of ADPHC, said the new collaborative system will contribute toward better communication with patients and possible contacts, and take the appropriate preventative measures towards each case.

Source: Emirates News Agency

ABU DHABI, The Ministry of Health and Prevention (MoHAP), in collaboration with the Department of Health – Abu Dhabi (DoH) and Dubai Health Authority (DHA), has announced the treatment results for Sotrovimab, an anti-viral treatment for severe COVID-19 cases in adults, pregnant women and children aged 12 and above who are at risk of progressing to severe symptoms and meet other relevant criteria.

The MoHAP has approved the use of Sotrovimab, which is produced by global biopharmaceutical company GlaxoSmithKline (GSK), after conducting local evaluation. It has also been approved for emergency use by the US Food and Drug Administration.

Between 16-29 June, Sotrovimab was administered to 658 patients with COVID-19, 46 percent of whom are citizens and 54 percent of whom are residents. About 59 percent of the patients are aged 50 or above.

More than 97.3 percent of recipients showed improvement within five to seven days and, as symptoms subsided, neared full recovery. Patients receiving Sotrovimab fall within at-risk groups due to other comorbidities that have been associated with severe COVID-19, such as obesity, cancer, kidney disease, lung disease, cardiovascular disease, diabetes, hypertension and allergies.

Sotrovimab is a monoclonal antibody treatment delivered through intravenous therapy in accordance with protocols developed by the National Scientific Committee.

The UAE was one of the first countries in the world to receive a shipment of Sotrovimab in mid-June, following an agreement between the Department of Health – Abu Dhabi, Rafed, a leading group purchasing organisation, GSK and Etihad Cargo.

Source: Emirates News Agency